|
"高嘉宏"的相關文件
顯示項目 71-95 / 491 (共20頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients
|
Wu, Hui-Lin; Hsiao, Tzu-Hung; Chen, Pei-Jer; Wong, Siao-Han; Kao, Jia-Horng; Chen, Ding-Shinn; Lu, Jo-Yang; Lu, Tzu-Pin; Chen, Yidong; Chuang, Eric Y.; Tu, Hui-Chu; Liu, Chun-Jen; 陳定信; 高嘉宏; 盧子彬; 吳慧琳; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2016 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang; Yang, Hung-Chih; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Tzu-San; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 高嘉宏; 楊宏志 |
| 國立臺灣大學 |
2016 |
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C
|
Mah, Yone-Han; Liu, Chen-Hua; Chen, Chi-Ling; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis
|
Yang, Hwai-I; Tseng, Tai-Chung; Liu, Jessica; Lee, Mei-Hsuan; Liu, Chun-Jen; Su, Tung-Hung; Batrla-Utermann, Richard; Chan, Henry Lik-Yuen; Kao, Jia-Horng; Chen, Chien-Jen; 陳建仁; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2016 |
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Perspectives on dual hepatitis B and C infection in Taiwan
|
Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Tseng, Tai-Chung; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2016 |
Review article: novel therapies for hepatitis B virus cure - advances and perspectives
|
Lin, C. -L.; Kao, J. -H.; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
|
Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Tsai-Yuan; Peng, Cheng-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Hepatitis C Virus and Lymphoma REPLY
|
Su, Tung-Hung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 陳祈玲 |
| 國立臺灣大學 |
2016 |
HBV genotype is associated with early (week 12) virologic response during TDF or TAF therapy in patients with chronic hepatitis B
|
Acharya, Subrat K.; Lee, Kwan Sik; Kao, Jia-Horng; Flisiak, Robert; Flaherty, John F.; Kim, Kyungpil; Lin, Lanjia; Gaggar, Anuj; Myers, Robert P.; Osipenko, Marina; Pianko, Stephen; Chow, Wan-Cheng; Pan, Calvin Q.; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
|
Wang, Chia-Chi; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Faldaprevir, pegylated interferon, and ribavirin for treatment-naive HCV genotype-1: pooled analysis of two phase 3 trials
|
Jensen, Donald M.; Asselah, Tank; Dieterich, Douglas; Foster, Graham R.; Sulkowski, Mark S.; Zeuzem, Stefan; Manny, Parvez; Yoshida, Eric M.; Moreno, Christophe; Ouzan, Denis; Wright, Mark; Morano, Luis E.; Buynak, Robert; Bourliere, Marc; Hassanein, Tarek; Nishiguchi, Shuhei; Kao, Jia-Horng; Omata, Masao; Paik, Seung W.; Wong, David K.; Tam, Edward; Kaita, Kelly; Feinman, S. Victor; Stern, Jerry O.; Scherer, Joseph; Quinson, Anne-Marie; Voss, Florian; Gallivan, John-Paul; Boecher, Wulf O.; Ferenci, Peter; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Hepatitis C Viral Infection Increases the Risk of Lymphoid-Neoplasms: A Population-Based Cohort Study
|
Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Chou, Shih-Wan; Liu, Chen-Hua; Yang, Hung-Chih; Wu, Shang-Ju; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Chi-Ling; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 吳尚儒; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
|
Sarin, S. K.; Kumar, M.; Lau, G. K.; Abbas, Z.; Chan, H. L. Y.; Chen, C. J.; Chen, D. S.; Chen, H. L.; Chen, P. J.; Chien, R. N.; Dokmeci, A. K.; Gane, Ed; Hou, J. L.; Jafri, W.; Jia, J.; Kim, J. H.; Lai, C. L.; Lee, H. C.; Lim, S. G.; Liu, C. J.; Locarnini, S.; Al Mahtab, M.; Mohamed, R.; Omata, M.; Park, J.; Piratvisuth, T.; Sharma, B. C.; Sollano, J.; Wang, F. S.; Wei, L.; Yuen, M. F.; Zheng, S. S.; Kao, J. H.; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2016 |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients
|
Hsu, Yao-Chun; Mo, Lein-Ray; Chang, Chi-Yang; Wu, Ming-Shiang; Kao, Jia-Horng; Wang, Wen-Lun; Yang, Tzeng-Huey; Wang, Chaur-Shine; Chiang, Ming-Feng; Chen, Chieh-Chang; Fang, Yu-Jen; Hung, Hsu-Wei; Wu, Chun-Ying; Lin, Jaw-Town; 高嘉宏; 吳明賢; 方佑仁; 陳介章 |
| 國立臺灣大學 |
2016 |
HIV/HCV Coinfection in Taiwan
|
Hsu, Ching-Sheng; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: fact or fiction?
|
Liu, Chen-Hua; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus
|
Su, Tung-Hung; Liu, Chun-Jen; Shu, Pei-Yun; Fu, Yang-Hsien; Chang, Chi-Hsien; Jao, Ping; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2016 |
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
|
Wang, Chia-Chi; Lin, Chih-Lin; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Su, Tung-Hung; Yang, Sheng-Shun; Hsu, Yu-Chun; Chen, Tsung-Ming; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2016 |
How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
|
Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Hung-Chih; Chen, Chi-Ling; Yang, Wan-Ting; Tsai, Cheng-Shiue; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
HBV cure-can we pin our hopes on immunotherapy?
|
Yang, Hung-Chih; Kao, Jia-Horng; 高嘉宏; 楊宏志 |
顯示項目 71-95 / 491 (共20頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
